An Overview of the 2009 A(H1N1) Pandemic in Europe: Efficiency of the Vaccination and Healthcare Strategies

Samanlıoğlu, Funda; Bilge, Ayşe Hümeyra

doi:10.1155/2016/5965836

Cited by 9 publications

(14 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Between one third and one half of the population was vaccinated over the remainder of the pandemic [114]. Vaccination coverage was lower in the United States (with state averages from 12.9% to 38.8%) [115], and much of Europe, with the exception of Norway (45%) and Sweden (59%) [116]. Unfortunately, there was little use of antivirals before September 2009, though awareness campaigns targeting primary care providers increased their use to treat patients later in the pandemic [104].…”

Section: 2009–2010: Swine Flumentioning

confidence: 99%

Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission

2016

View full text Add to dashboard Cite

For centuries, novel strains of influenza have emerged to produce human pandemics, causing widespread illness, death, and disruption. There have been four influenza pandemics in the past hundred years. During this time, globalization processes, alongside advances in medicine and epidemiology, have altered the way these pandemics are experienced. Drawing on international case studies, this paper provides a review of the impact of past influenza pandemics, while examining the evolution of our understanding of, and response to, these viruses. This review argues that pandemic influenza is in part a consequence of human development, and highlights the importance of considering outbreaks within the context of shifting global landscapes. While progress in infectious disease prevention, control, and treatment has improved our ability to respond to such outbreaks, globalization processes relating to human behaviour, demographics, and mobility have increased the threat of pandemic emergence and accelerated global disease transmission. Preparedness planning must continue to evolve to keep pace with this heightened risk. Herein, we look to the past for insights on the pandemic experience, underlining both progress and persisting challenges. However, given the uncertain timing and severity of future pandemics, we emphasize the need for flexible policies capable of responding to change as such emergencies develop.

show abstract

Section: 2009–2010: Swine Flumentioning

confidence: 99%

Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission

2016

View full text Add to dashboard Cite

show abstract

“…During the 2009 A(H1N1) influenza pandemic, in EU, Hungary started vaccination first, and by July 2010, about 9% was vaccinated in EU/EEA [3]. However, in most of the countries, vaccination campaigns were not as effective as planned due to the timing and the percentage of coverage [5]. Norway and Sweden were compared in terms of their vaccination strategies in a previous study [5].…”

Section: Introductionmentioning

confidence: 99%

“…However, in most of the countries, vaccination campaigns were not as effective as planned due to the timing and the percentage of coverage [5]. Norway and Sweden were compared in terms of their vaccination strategies in a previous study [5]. In Sweden, vaccination campaign was more effective than Norway.…”

Section: Introductionmentioning

confidence: 99%

“…In Sweden, vaccination campaign was more effective than Norway. Even though vaccination started almost the same time in both countries and although about 40% of population got vaccinated, in Norway, it was too late to be effective due to the relative timing of the starting time of vaccination and its location in the epidemic wave [5–7]. As discussed in Samanlioglu and Bilge's study [5], for the vaccination campaign to be effective, vaccination should start in the early phases of the epidemic, but it does not need to continue over the peak of the epidemic.…”

Section: Introductionmentioning

confidence: 99%

“…Even though vaccination started almost the same time in both countries and although about 40% of population got vaccinated, in Norway, it was too late to be effective due to the relative timing of the starting time of vaccination and its location in the epidemic wave [5–7]. As discussed in Samanlioglu and Bilge's study [5], for the vaccination campaign to be effective, vaccination should start in the early phases of the epidemic, but it does not need to continue over the peak of the epidemic. The effect of vaccination timing and sales of antivirals in Norway were analysed, and they showed that the countermeasures only prevented 11-12% of the potential cases relative to an unmitigated pandemic, and that if the campaign would have started 6 weeks earlier, the vaccination alone might have reduced the clinical attack rate by 50% [6].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Evaluation of Influenza Intervention Strategies in Turkey with Fuzzy AHP-VIKOR

Samanlıoğlu

2019

Journal of Healthcare Engineering

Self Cite

View full text Add to dashboard Cite

In this study, a fuzzy AHP-VIKOR method is presented to help decision makers (DMs), especially physicians, evaluate and rank intervention strategies for influenza. Selecting the best intervention strategy is a sophisticated multiple criteria decision-making (MCDM) problem with potentially competing criteria. Two fuzzy MCDM methods, fuzzy analytic hierarchy process (F-AHP) and fuzzy VIsekriterijumska optimizacija i KOmpromisno Resenje (F-VIKOR), are integrated to evaluate and rank influenza intervention strategies. In fuzzy AHP-VIKOR, F-AHP is used to determine the fuzzy criteria weights and F-VIKOR is implemented to rank the strategies with respect to the presented criteria. A case study is given where a professor of infectious diseases and clinical microbiology, an internal medicine physician, an ENT physician, a family physician, and a cardiologist in Turkey act as DMs in the process.

show abstract

Vaccination or NPI? A conjoint analysis of German citizens' preferences in the context of the COVID-19 pandemic

et al. 2022

View full text Add to dashboard Cite

This research uses discrete choice-based conjoint analysis that elicits the preference structure of German citizens when it comes to their timely intention to vaccinate. The focus is on the trade-offs between pharmaceuticals (vaccine) and "non-pharmaceutical interventions" (NPIs) such as lock-downs and social distancing measures, as well as the value of voluntary versus mandatory compliance to the citizens. Our results highlight three critical insights: (a) value of waiting: at 70% effective vaccine, 1/3 of citizens still would prefer to be vaccinated in the next 6 months rather than immediately; (b) costs of NPI constraints: an effective vaccine may come as a solution to compensate for the costs induced by invasive NPI imposed for an extended period; (c) freedom of choice: voluntary compliance is preferred by citizens over imposed measures whether it relates to vaccination choice, lock-down measures, or work location choice during the pandemic. Backing up those findings in monetary value, a quick shot of a 100% effective vaccination is estimated to be worth in the range of 11,400€. Still, the value of the shot quickly falls to no value when effectiveness drops below 50. At the same time, the cost of imposing protective rules lies in the range of 1500–2500€, depending on the rule analyzed. In comparison, the burden of extra complete lock-down and social distancing is about 775€ per citizen per month. As most current vaccines are being proven to have high efficacy, a strategy that selects the most effective vaccine candidates while emphasizing how the vaccine may stop the pain of lasting lock-downs will be appropriate to nudge the population towards vaccination. Control measures that are too restrictive may be welfare-deteriorating, but enough NPI measures must be recommended as long as vaccination adoption is not sufficiently large.

show abstract

An Overview of the 2009 A(H1N1) Pandemic in Europe: Efficiency of the Vaccination and Healthcare Strategies

Cited by 9 publications

References 29 publications

Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission

Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission

Evaluation of Influenza Intervention Strategies in Turkey with Fuzzy AHP-VIKOR

Vaccination or NPI? A conjoint analysis of German citizens' preferences in the context of the COVID-19 pandemic

Contact Info

Product

Resources

About